OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Kris on Search for Biomarkers in Advanced Squamous NSCLC

November 13th 2019

Mark G. Kris, MD, discusses the ongoing search for additional biomarkers in advanced squamous non–small cell lung cancer.

Dr. Borello on Treating Indolent Versus Aggressive Relapsed Multiple Myeloma

November 12th 2019

Ivan M. Borrello, MD, discusses treatment for patients with indolent versus aggressive relapsed multiple myeloma.

Dr. Gogineni on Implications of the APT Trial in HER2+ Breast Cancer

November 12th 2019

Keerthi Gogineni, MD, MSHP, discusses the clinical implications of the phase II APT trial in HER2-positive breast cancer.

Dr. Ocean on Efforts to Improve Early Detection in Pancreatic Cancer

November 12th 2019

Allyson Ocean, MD, discusses efforts to improve early detection rates in pancreatic cancer.

Dr. Backes on Safety Profile of Lenvatinib and Weekly Paclitaxel in Endometrial Cancer

November 12th 2019

Floor J. Backes, MD, discusses the safety profile from a phase I study looking at lenvatinib and weekly paclitaxel in women with recurrent endometrial cancer.

Dr. Hamilton on the Impact of Biosimilars in Oncology

November 12th 2019

Erika P. Hamilton, MD, discusses the impact of biosimilars in oncology.

Dr. Jonasch on Modulating the Tumor Microenvironment in RCC

November 12th 2019

Eric Jonasch, MD, discusses how to modulate the tumor microenvironment in renal cell carcinoma.

Dr. Yadav on Differences in Type 1 and Type 2 Uterine Cancer

November 12th 2019

Ghanshyam Yadav, MD, discusses the differences between type 1 and type 2 uterine cancer.

The Heterogeneity of Biologics

November 12th 2019

Jim M. Koeller, MS FHOPA, discusses the heterogeneity of biologics.

Dr. Stiles on Surgical Considerations in Lung Cancer

November 12th 2019

Brendon Stiles, MD, discusses considerations for surgery in lung cancer.

Dr. Eng on Unmet Needs in Early-Onset CRC

November 12th 2019

Cathy Eng, MD, FACP, FASCO, discusses unique barriers facing patients with early-onset colorectal cancer.

Dr. Ho on First-Line TKI Monotherapy in mRCC

November 12th 2019

Thai H. Ho, MD, PhD, discusses the role of TKI monotherapy in the first-line treatment of patients with metastatic renal cell carcinoma.

Dr. Cosgrove on Selecting a PARP Inhibitor for Maintenance Therapy in Ovarian Cancer

November 12th 2019

Casey M. Cosgrove, MD, discusses factors to consider when selecting a PARP inhibitor as maintenance therapy in advanced ovarian cancer.

Dr. Lonial on Treating Early Relapse in Multiple Myeloma

November 12th 2019

Sagar Lonial, MD, FACP, discusses the management of patients with relapsed multiple myeloma.

Dr. McDermott on TKI/Immunotherapy Combinations in RCC

November 12th 2019

David F. McDermott, MD, discusses the combination of VEGF TKIs and PD-1 inhibitors in advanced renal cell carcinoma.

Dr. Offin on Targeted Agents in MET- and RET-Altered NSCLC

November 12th 2019

Michael D. Offin, MD, discusses targeted agents in MET- and RET-altered non–small cell lung cancer.

Dr. Somer on Lowering the Cost of Cancer Care With Biosimilars

November 12th 2019

Bradley G. Somer, MD, discusses lowering the cost of cancer care with biosimilars.

Dr. Essel on Rationale to Explore Quantitative CT Image Feature Analysis in Gynecologic Cancers

November 9th 2019

Kathleen G. Essel, MD, discusses the rationale to explore quantitative computed tomography image feature analysis in gynecologic cancers.

Dr. Tauer on Arguments in Favor of and Against Biosimilars in Oncology

November 9th 2019

Kurt Tauer, MD, FACP, discusses arguments in favor of and against biosimilars in oncology.

Dr. Lai on the Results of the CASPIAN Trial in Small Cell Lung Cancer

November 9th 2019

W. Victoria Lai, MD, discusses the results of the phase III CASPIAN trial in small cell lung cancer.